导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.49% | 986/4773 |
| 近一周 | -1.00% | 2036/5467 |
| 近一月 | -4.91% | 2013/5421 |
| 近一季 | -9.71% | 3099/5238 |
| 近半年 | 0.57% | 1501/4931 |
| 近一年 | 10.40% | 1010/4400 |
| 近两年 | 83.43% | 788/2954 |
| 近三年 | 48.37% | 580/2253 |
| 成立以来 | 42.29% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.38% 950/4961 |
21.25% 1184/5312 |
- - |
- - |
| 2025 | 30.74% 1295/4813 |
5.99% 698/3635 |
3.86% 932/4076 |
18.25% 2322/4524 |
0.43% 2000/4813 |
| 2024 | 10.75% 1380/3463 |
-1.79% 1281/2808 |
-2.47% 1194/3014 |
11.61% 2492/3129 |
3.60% 790/3463 |
| 2023 | -0.10% 435/2656 |
8.27% 473/2280 |
-1.25% 461/2385 |
-1.50% 532/2515 |
-5.15% 1270/2655 |
| 2022 | -19.71% 887/2207 |
-11.84% 547/1919 |
3.68% 1110/2016 |
-9.03% 240/2113 |
-3.44% 1851/2208 |
| 2021 | -2.26% 841/1822 |
-5.75% 955/1255 |
11.73% 362/1330 |
-8.29% 1123/1466 |
1.21% 984/1822 |
| 2020 | 20.32% 720/1250 |
-5.30% 407/1028 |
23.59% 190/1067 |
0.66% 1039/1164 |
2.13% 1009/1184 |
| 2019 | 35.32% 380/1092 |
25.86% 443/754 |
-5.25% 463/804 |
4.27% 206/850 |
8.83% 281/918 |
| 2018 | -28.39% 440/834 |
- - |
- - |
- - |
-13.25% 520/691 |
| 2017 | 12.44% 275/714 |
- - |
- - |
- - |
- - |
| 2016 | 2.35% 84/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 博时中证淘金大数据100A VS. 长安沪深300非周期A(740101) |